Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-127300
Filing Date
2024-12-10
Accepted
2024-12-10 18:14:56
Documents
1
Period of Report
2024-12-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2430692-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2430692-1_4seq1.xml 4 6231
  Complete submission text file 0001104659-24-127300.txt   7898
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15
Business Address
Divis Gregory J (Reporting) CIK: 0001410677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37977 | Film No.: 241539640